US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

126.63

+15.6814.13%

Post-market: 126.06-0.5737-0.45%16:36 EDT

Volume:3.49M

Turnover:442.83M

Market Cap:5.29B

PE:-19.65

High:136.72

Open:111.60

Low:110.56

Close:110.95

52wk High:136.72

52wk Low:32.00

Shares:41.78M

Float Shares:32.29M

Volume Ratio:5.48

T/O Rate:10.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:6.50

PE(LYR):-1.13

Loading ...

Overview Company News Filings

Movement Alert｜Veradermics, Inc. Rises 17.35% in Regular Trading, Hits Record High

US Stocks on the MOVE-Palantir, Haemonetics

Veradermics rises 20.8%

Buy/High Risk Rating Reiterated on MANE as Phase 3 Hair Loss Catalyst Nears; $160 Price Target Maintained

Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data

Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE)

Jefferies Remains a Buy on Veradermics, Incorporated (MANE)

Veradermics Management to Attend September Investor Conferences

Montanova Capital Reports Disposal of 750,000 Veradermics Common Shares Worth $80.44 Million

Veradermics Files Form 3 for Chief R&D Officer David Hollander

Veradermics CEO Reid Alexander Waldman Disposes of Common Shares Worth $7.24 Million

Veradermics Director John W. Childs Disposes of USD 10.18 Million in Common Shares

Citi Sticks to Its Buy Rating for Veradermics, Incorporated (MANE)

Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164

Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate

Benzinga Earnings

Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss

MT Newswires Live

Veradermics sees cash runway into 2030

Veradermics Q2 FY26 Net Loss Widens to $23.5 Million; R&D Expense Rises to $18.61 Million

Veradermics Inc Q2 Operating Expenses USD 29.553 Million

THOMSON REUTERS

Press Release: Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MANE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":126.63,"timestamp":1791489600000,"preClose":110.95,"halted":0,"volume":3489699,"hourTrading":{"tag":"盘后","latestPrice":126.0563,"preClose":126.63,"latestTime":"16:36 EDT","volume":5225,"amount":661593.3142499999,"timestamp":1791491770645,"change":-0.5737,"changeRate":-0.004531,"amplitude":0.043434},"delay":0,"changeRate":0.14132492113564663,"floatShares":32290700,"shares":41778687,"eps":-6.443948,"marketStatus":"Post-Mkt","change":15.68,"latestTime":"10-08 16:37:33 EDT","open":111.6,"high":136.715,"low":110.56,"amount":442828006.77624,"amplitude":0.235737,"askPrice":127,"askSize":1,"bidPrice":126.01,"bidSize":70,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":110.95,"preHourTrading":{"tag":"盘前","latestPrice":111.6,"preClose":110.95,"latestTime":"09:29 EDT","volume":3804,"amount":423629.54994,"timestamp":1791466199999,"change":0.65,"changeRate":0.005858,"amplitude":0.037855},"postHourTrading":{"tag":"盘后","latestPrice":126.0563,"preClose":126.63,"latestTime":"16:36 EDT","volume":5225,"amount":661593.3142499999,"timestamp":1791491770645,"change":-0.5737,"changeRate":-0.004531,"amplitude":0.043434},"volumeRatio":5.475405,"impliedVol":1.2597,"impliedVolPercentile":0.9836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":32290700,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":5.475405,"shares":41778687,"dividePrice":0,"high":136.715,"amplitude":0.235737,"preClose":110.95,"low":110.56,"week52Low":32,"pbRate":"6.50","week52High":136.715,"institutionHeld":0,"latestPrice":126.63,"committee":0.971831,"eps":-6.443948,"divideRate":0,"volume":3489699,"delay":0,"ttmEps":-6.443948,"open":111.6,"prevYearClose":17,"prevWeekClose":116.76,"prevMonthClose":121.23,"prevQuarterClose":121.23,"fiveDayClose":117.22,"twentyDayClose":98.14,"sixtyDayClose":123.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-10-07","current":-19.650997,"percent":0.431953,"low":-67.545361,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"high":-9.296992,"avg":-45.829099,"sd":10.305782,"marketCap":4552363618},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923},{"date":"2026-08-28","current":-45.893958,"twenty":-54.263485,"median":-47.316049,"eighty":-33.861631,"marketCap":4253635646},{"date":"2026-09-04","current":-44.06379,"twenty":-54.197488,"median":-46.684099,"eighty":-34.12449,"marketCap":4084008294},{"date":"2026-09-11","current":-44.239594,"twenty":-54.067463,"median":-46.421397,"eighty":-34.344005,"marketCap":4100302547},{"date":"2026-09-18","current":-48.99082,"twenty":-53.916605,"median":-46.349247,"eighty":-34.830885,"marketCap":4540665180},{"date":"2026-09-25","current":-52.164315,"twenty":-53.806823,"median":-46.818058,"eighty":-35.200053,"marketCap":4834797337},{"date":"2026-10-02","current":-52.840485,"twenty":-53.806823,"median":-47.237246,"eighty":-35.451255,"marketCap":4897467541},{"date":"2026-10-07","current":-49.117039,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"marketCap":4552363618}],"updateTime":1791491853615},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102517021","title":"Movement Alert｜Veradermics, Inc. Rises 17.35% in Regular Trading, Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1102517021","media":"Market Focus","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1102517021?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:45","pubTimestamp":1791477942,"startTime":"0","endTime":"0","summary":"On October 8, Veradermics, Inc. rose 17.35% in regular trading, trading at $130.215/share with a turnover of $289 million, marking its largest single-day gain since April. The rally followed ongoing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Veradermics Hits Record High on 90% Hair Regrowth Data","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674042200","title":"US Stocks on the MOVE-Palantir, Haemonetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2674042200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674042200?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:15","pubTimestamp":1791483328,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Palantir, HaemoneticsOct 8 (Reuters)-US stocks fell on Thursday as a surge in oil prices and Treasury yields near multi-year highs stoked inflation worries before a crucial ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nL6N45U0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX","DVN","GDDY","BE","IONQ","FEDU","09311","HAE","BETR","SXTC","AIXI","CMG","RNA","MO","CSL.AU","HUT","GNRC","OLED","PM","RIOT","DKI","CVX","COP","HUBS","MANE","XOM","STZ","SBUX","VTRS","COHR","CABO","APLD","CSGP","FLYE","JZ","LEVI","PLTR","OXY","PEP","AMTD","HNRG","MARA","GFS","HSIC","HELE","LITE","GLAS","RCL","COIN","SBFM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003120","title":"Veradermics rises 20.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003120","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003120?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:05","pubTimestamp":1791468336,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) is up 20.8%, or $23.05 to $134.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-rises-20-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-rises-20-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964953","title":"Buy/High Risk Rating Reiterated on MANE as Phase 3 Hair Loss Catalyst Nears; $160 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964953","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964953?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:36","pubTimestamp":1789468608,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Veradermics, Incorporated today and set a price target of $160.00. Geoff Meacham has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-high-risk-rating-reiterated-on-mane-as-phase-3-hair-loss-catalyst-nears-160-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-high-risk-rating-reiterated-on-mane-as-phase-3-hair-loss-catalyst-nears-160-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264696","title":"Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264696?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:10","pubTimestamp":1789467050,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham adds an “upside 90-day catalyst watch” on Veradermics (MANE) while keeping a Buy rating on the shares with a $160 price ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-opens-upside-90-day-catalyst-watch-on-veradermics-into-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-opens-upside-90-day-catalyst-watch-on-veradermics-into-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666621485","title":"Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666621485","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666621485?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035403,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Veradermics, Incorporated today and set a price target of $160.00. According to TipRanks, Mea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665758883","title":"Jefferies Remains a Buy on Veradermics, Incorporated (MANE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665758883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665758883?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:05","pubTimestamp":1788872734,"startTime":"0","endTime":"0","summary":"In a report released today, from Jefferies maintained a Buy rating on Veradermics, Incorporated, with a price target of $182.00. The word on The St...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804258","title":"Veradermics Management to Attend September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804258","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804258?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:33","pubTimestamp":1788471193,"startTime":"0","endTime":"0","summary":"Veradermics management to attend September investor conferencesVeradermics management to hold investor meetings at the Wells Fargo 21st Annual Healthcare Conference on Tuesday, Sept. 8, 2026, in Bosto","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL6DLQB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","IE00BSNM7G36.USD","LU2125154778.USD","BK4585","LU0170899867.USD","LU0310800965.SGD","LU0130102774.USD","BK4207","LU1244550494.USD","BK4559","LU0130517989.USD","LU1791807156.HKD","LU0072461881.USD","FTXO","LU0106831901.USD","IYF","TFNS","LU1244550577.SGD","LU1144417596.USD","LU1267930227.SGD","LU2417539215.USD","LU0128525689.USD","MANE","BK4566","LU0648001328.SGD","LU2360032135.SGD","BK4588","LU0320765646.SGD","BK4534","LU0980610538.SGD","LU1201861249.SGD","LU2125154935.USD","BK4007","LU2236285917.USD","LU1244550221.USD","LU1506573853.SGD","LU1074936037.SGD","LU0052756011.USD","LU0477156953.USD","LU0203347892.USD","LU0098860793.USD","LU1668664300.SGD","LU2456880835.USD","LU0162691827.USD","LU2462157665.USD","LU0203345920.USD","LU0314106906.USD","LU1162221912.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218305","title":"Montanova Capital Reports Disposal of 750,000 Veradermics Common Shares Worth $80.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218305","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218305?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:12","pubTimestamp":1787350329,"startTime":"0","endTime":"0","summary":"Montanova Capital reports disposal of 750,000 Veradermics common shares worth $80.44 millionMontanova Capital filed a Form 4 reporting sales of Veradermics common stock on Aug. 19 at USD 107.25.The fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL9plFnH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Montanova Capital Reports Disposal of 750,000 Veradermics Common Shares Worth $80.44 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661585482","title":"Veradermics Files Form 3 for Chief R&D Officer David Hollander","url":"https://stock-news.laohu8.com/highlight/detail?id=2661585482","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661585482?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:05","pubTimestamp":1787267122,"startTime":"0","endTime":"0","summary":"Veradermics files Form 3 for Chief R&D Officer David HollanderVeradermics filed an initial Form 3 for Chief R&D Officer David Hollander, dated Aug. 10, 2026.Disclaimer:This news brief was created by P","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLbyGD6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413717","title":"Veradermics CEO Reid Alexander Waldman Disposes of Common Shares Worth $7.24 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413717","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413717?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:05","pubTimestamp":1787101527,"startTime":"0","endTime":"0","summary":"Veradermics CEO Reid Alexander Waldman disposes of common shares worth $7.24 millionVeradermics CEO Reid Alexander Waldman cut his stake to 170,824 shares in an Aug. 17 filing.Sales totaled 67,500 sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL58Lcdw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veradermics CEO Reid Alexander Waldman Disposes of Common Shares Worth $7.24 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659284124","title":"Veradermics Director John W. Childs Disposes of USD 10.18 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659284124","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659284124?lang=en_us&edition=fundamental","pubTime":"2026-08-15 06:04","pubTimestamp":1786745047,"startTime":"0","endTime":"0","summary":"Veradermics director John W. Childs disposes of USD 10.18 million in common sharesVeradermics director John W. Childs sold 100,000 common shares on Aug. 12.Sales priced at USD 106.14 to USD 108.24 per","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4szw73:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veradermics Director John W. Childs Disposes of USD 10.18 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166490","title":"Citi Sticks to Its Buy Rating for Veradermics, Incorporated (MANE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166490?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:05","pubTimestamp":1786637135,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Veradermics, Incorporated today and set a price target of $160.00. Meacham covers the Healthc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659040969","title":"Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164","url":"https://stock-news.laohu8.com/highlight/detail?id=2659040969","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659040969?lang=en_us&edition=fundamental","pubTime":"2026-08-13 02:15","pubTimestamp":1786558525,"startTime":"0","endTime":"0","summary":"Needham analyst Serge Belanger maintained a Buy rating on Veradermics, Incorporated today and set a price target of $164.00. Serge Belanger has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-strong-vdphl01-data-and-catalyst-rich-roadmap-price-target-maintained-at-164-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-strong-vdphl01-data-and-catalyst-rich-roadmap-price-target-maintained-at-164-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945103","title":"Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945103","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945103?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:54","pubTimestamp":1786481689,"startTime":"0","endTime":"0","summary":"Veradermics (NYSE:MANE) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.65) by 10.77 percent. This is a 97.6 percent increase over losses of $(24.19) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61129038/veradermics-q2-eps-0-58-beats-0-65-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658499798","title":"Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658499798","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658499798?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:44","pubTimestamp":1786448657,"startTime":"0","endTime":"0","summary":"Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658697997","title":"Veradermics sees cash runway into 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2658697997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658697997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448529,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents, and marketable securities totaled $819.9 million as of June 30, 2026 including net proceeds from our follow-on offering com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-sees-cash-runway-into-2030-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-sees-cash-runway-into-2030-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658028992","title":"Veradermics Q2 FY26 Net Loss Widens to $23.5 Million; R&D Expense Rises to $18.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658028992","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658028992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:30","pubTimestamp":1786447854,"startTime":"0","endTime":"0","summary":"Veradermics Q2 FY26 net loss widens to $23.5 million; R&D expense rises to $18.61 millionVeradermics posted a GAAP net loss of USD 23.5 million in Q2 2026, widening from USD 15.6 million a year earlie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLbDgFkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658015992","title":"Veradermics Inc Q2 Operating Expenses USD 29.553 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658015992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658015992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:30","pubTimestamp":1786447800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLXB6ZJ8Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997893","title":"Press Release: Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997893","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997893?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:30","pubTimestamp":1786447800,"startTime":"0","endTime":"0","summary":"Hair Loss: In July 2026, Veradermics announced positive topline results. from its open-label Phase 2 clinical trial  evaluating","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4007","LU2065732104.USD","MANE","BID","PRGS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":114,"code":"91000000","status":"200"}]}}